NEUROCRINE Trademark

Trademark Overview

On Monday, October 15, 2018, a trademark application was filed for NEUROCRINE with the United States Patent and Trademark Office. The USPTO has given the NEUROCRINE trademark a serial number of 88155301. The federal status of this trademark filing is REGISTERED as of Tuesday, June 27, 2023. This trademark is owned by Neurocrine Biosciences, Inc.. The NEUROCRINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions
neurocrine

General Information

Serial Number88155301
Word MarkNEUROCRINE
Filing DateMonday, October 15, 2018
Status700 - REGISTERED
Status DateTuesday, June 27, 2023
Registration Number7093757
Registration DateTuesday, June 27, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions
Pseudo MarkNEURO CRINE; NEURO ENDOCRINE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 25, 2018
Primary Code005
First Use Anywhere DateWednesday, April 26, 2017
First Use In Commerce DateWednesday, April 26, 2017

Trademark Owner History

Party NameNeurocrine Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Thursday, January 31, 2019PRIORITY ACTION WRITTEN
Thursday, October 18, 2018NEW APPLICATION ENTERED
Thursday, October 25, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 24, 2019ASSIGNED TO EXAMINER
Thursday, January 31, 2019PRIORITY ACTION E-MAILED
Thursday, January 31, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, July 24, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 24, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 15, 2019FINAL REFUSAL WRITTEN
Thursday, August 15, 2019FINAL REFUSAL E-MAILED
Thursday, August 15, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 11, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 11, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, February 11, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 11, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, February 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 18, 2020ASSIGNED TO LIE
Wednesday, March 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 24, 2020PUBLISHED FOR OPPOSITION
Tuesday, March 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 28, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, October 28, 2020SOU EXTENSION 1 FILED
Wednesday, October 28, 2020SOU EXTENSION 1 GRANTED
Friday, October 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 19, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 19, 2021SOU EXTENSION 2 FILED
Monday, May 24, 2021ASSIGNED TO EXAMINER
Thursday, May 27, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 27, 2021SOU EXTENSION 2 GRANTED
Friday, May 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 19, 2021SOU TEAS EXTENSION RECEIVED
Friday, November 19, 2021SOU EXTENSION 3 FILED
Friday, November 19, 2021SOU EXTENSION 3 GRANTED
Tuesday, November 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 18, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 18, 2022SOU EXTENSION 4 FILED
Wednesday, May 18, 2022SOU EXTENSION 4 GRANTED
Friday, May 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 20, 2022SOU TEAS EXTENSION RECEIVED
Thursday, October 20, 2022SOU EXTENSION 5 FILED
Monday, October 24, 2022SOU EXTENSION 5 GRANTED
Tuesday, October 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 17, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, May 17, 2023USE AMENDMENT FILED
Thursday, May 18, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, May 19, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, May 20, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 27, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, June 27, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 20, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 20, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 20, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 20, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

neurocrine movement psychiatric diseases disorders conditions system nervous human preparations treatment